FDA Approved: ALECENSA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved ALECENSA (alectinib hydrochloride) from Genentech under NDA208434 as an original application for the treatment of ALK-positive non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alecensa (alectinib)

Snippet

ORIG AP for ALECENSA (ALECTINIB HYDROCHLORIDE)